BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,346K data for 622K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

Advanced Search

8 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
(±) cis-Bisamido epoxides: A novel series of potent FXIII-A inhibitors.EBI
University Of Leeds
Novel insights into structure and function of factor XIIIa-inhibitor tridegin.EBI
University Of Bonn
Tissue transglutaminase: an emerging target for therapy and imaging.EBI
TBA
Imidazolium-based warheads strongly influence activity of water-soluble peptidic transglutaminase inhibitors.EBI
Aston University
Discovery and structure-activity relationship of potent and selective covalent inhibitors of transglutaminase 2 for Huntington's disease.EBI
Evotec (Uk)
SAR Development of Lysine-Based Irreversible Inhibitors of Transglutaminase 2 for Huntington's Disease.EBI
TBA
Irreversible 4-Aminopiperidine Transglutaminase 2 Inhibitors for Huntington's Disease.EBI
TBA
3-Substituted imidazo[1,2-d][1,2,4]-thiadiazoles: a novel class of factor XIIIa inhibitors.EBI
Apotex Research